Medpace Inc.
MEDP | NASDAQ
$624.20
+$11.87 (+1.94%)
At close: Sep 21, 2026, 4:00 PM ET
$629.99
+$5.79 (+0.93%)
Pre-market:
Sep 22, 2026, 7:41 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.53B | 2.11B | 1.89B | 1.46B | 1.14B | 925.93M |
Cost of Revenue | 1.77B | 1.45B | 1.36B | 1.03B | 814.22M | 647.2M |
Gross Profit | 760.62M | 656.31M | 524.51M | 432.44M | 328.16M | 278.73M |
Operating Income | 534.94M | 446.87M | 336.83M | 278.7M | 198.62M | 167.04M |
Interest Income | n/a | 25M | n/a | n/a | n/a | 307K |
Pretax Income | 542.38M | 475.92M | 335.68M | 282.86M | 201.85M | 168.53M |
Net Income | 451.12M | 404.39M | 282.81M | 245.37M | 181.85M | 145.38M |
Selling & General & Admin | 197.56M | 180.18M | 161.35M | 131.4M | 108.42M | 92.16M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 28.12M | 29.25M | 26.33M | 22.34M | 21.12M | 19.53M |
Operating Expenses | 225.68M | 209.44M | 187.68M | 153.74M | 129.54M | 111.68M |
Interest Expense | n/a | n/a | 488K | 2.91M | 105K | n/a |
Selling & Marketing Expenses | n/a | 1.5M | n/a | n/a | n/a | n/a |
Cost & Expenses | 2B | 1.66B | 1.55B | 1.18B | 943.76M | 758.88M |
Income Tax Expense | 91.25M | 71.54M | 52.87M | 37.49M | 20M | 23.15M |
Shares Outstanding (Basic) | 28.85M | 30.96M | 30.72M | 32.39M | 35.86M | 35.64M |
Shares Outstanding (Diluted) | 29.53M | 32.01M | 31.84M | 33.67M | 37.7M | 37.71M |
EPS (Basic) | 15.64 | 13.06 | 9.20 | 7.57 | 5.06 | 4.07 |
EPS (Diluted) | 15.28 | 12.63 | 8.88 | 7.28 | 4.81 | 3.84 |
EBITDA | 570.5M | 505.17M | 362.5M | 308.11M | 223.08M | 186.57M |
EBIT | 542.38M | 475.92M | 336.17M | 285.77M | 201.96M | 167.04M |
Depreciation & Amortization | 28.12M | 29.25M | 26.33M | 22.34M | 21.12M | 19.53M |
Add to Watchlist
Select watchlists to add or remove MEDP